These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32147272)

  • 1. CDH1 gene mutation in early-onset, colorectal signet-ring cell carcinoma.
    Aitchison A; Hakkaart C; Whitehead M; Khan S; Siddique S; Ahmed R; Frizelle FA; Keenan JI
    Pathol Res Pract; 2020 May; 216(5):152912. PubMed ID: 32147272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer.
    Funakoshi T; Miyamoto S; Kakiuchi N; Nikaido M; Setoyama T; Yokoyama A; Horimatsu T; Yamada A; Torishima M; Kosugi S; Yamada H; Sugimura H; Haga H; Sakai Y; Ogawa S; Seno H; Muto M; Chiba T
    Gastric Cancer; 2019 Jul; 22(4):892-898. PubMed ID: 30542785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
    Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
    Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model.
    Yamaguchi K; Yoshihiro T; Ariyama H; Ito M; Nakano M; Semba Y; Nogami J; Tsuchihashi K; Yamauchi T; Ueno S; Isobe T; Shindo K; Moriyama T; Ohuchida K; Nakamura M; Nagao Y; Ikeda T; Hashizume M; Konomi H; Torisu T; Kitazono T; Kanayama T; Tomita H; Oda Y; Kusaba H; Maeda T; Akashi K; Baba E
    Gastric Cancer; 2022 Sep; 25(5):862-878. PubMed ID: 35661943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
    Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
    Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
    Barber M; Murrell A; Ito Y; Maia AT; Hyland S; Oliveira C; Save V; Carneiro F; Paterson AL; Grehan N; Dwerryhouse S; Lao-Sirieix P; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):295-306. PubMed ID: 18788075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
    Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
    Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Signet Ring Cell/Histiocytoid Carcinoma of the Eyelid: Somatic Mutations in
    Wang LC; Lin TC; Yeh YC; Ho HL; Tsai CC; Chou TY
    Curr Oncol; 2021 Feb; 28(1):918-927. PubMed ID: 33617508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations.
    Nikaido M; Kakiuchi N; Miyamoto S; Hirano T; Takeuchi Y; Funakoshi T; Yokoyama A; Ogasawara T; Yamamoto Y; Yamada A; Setoyama T; Shimizu T; Kato Y; Uose S; Sakurai T; Minamiguchi S; Obama K; Sakai Y; Muto M; Chiba T; Ogawa S; Seno H
    Gastric Cancer; 2021 Sep; 24(5):1102-1114. PubMed ID: 33961152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
    Adib E; El Zarif T; Nassar AH; Akl EW; Abou Alaiwi S; Mouhieddine TH; Esplin ED; Hatchell K; Nielsen SM; Rana HQ; Choueiri TK; Kwiatkowski DJ; Sonpavde G
    Br J Cancer; 2022 Mar; 126(5):797-803. PubMed ID: 34949788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach.
    Caggiari L; Miolo G; Canzonieri V; De Zorzi M; Alessandrini L; Corona G; Cannizzaro R; Santeufemia DA; Cossu A; Buonadonna A; De Re V
    Cancer Biol Ther; 2018 Apr; 19(4):254-259. PubMed ID: 29131691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status.
    Mi EZ; Mi EZ; di Pietro M; O'Donovan M; Hardwick RH; Richardson S; Ziauddeen H; Fletcher PC; Caldas C; Tischkowitz M; Ragunath K; Fitzgerald RC
    Gastrointest Endosc; 2018 Feb; 87(2):408-418. PubMed ID: 28688938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man.
    Humar B; Blair V; Charlton A; More H; Martin I; Guilford P
    Cancer Res; 2009 Mar; 69(5):2050-6. PubMed ID: 19223545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
    Kim H; Kim BH; Lee D; Shin E
    Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.
    Richards FM; McKee SA; Rajpar MH; Cole TR; Evans DG; Jankowski JA; McKeown C; Sanders DS; Maher ER
    Hum Mol Genet; 1999 Apr; 8(4):607-10. PubMed ID: 10072428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
    Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
    Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal signet ring cell carcinoma: Influence of EGFR, E-cadherin and MMP-13 expression on clinicopathological features and prognosis.
    Foda AAM; Aziz AA; Mohamed MA
    Ann Diagn Pathol; 2018 Feb; 32():41-46. PubMed ID: 29414397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and Molecular Characteristics of Colorectal Signet Ring Cell Carcinoma: A Review.
    An Y; Zhou J; Lin G; Wu H; Cong L; Li Y; Qiu X; Shi W
    Pathol Oncol Res; 2021; 27():1609859. PubMed ID: 34381313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies.
    Vos EL; Salo-Mullen EE; Tang LH; Schattner M; Yoon SS; Gerdes H; Markowitz AJ; Mandelker D; Janjigian Y; Offitt K; Coit DG; Stadler ZK; Strong VE
    JAMA Surg; 2020 Nov; 155(11):1050-1057. PubMed ID: 32997132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary diffuse gastric cancer in a Japanese family with a large deletion involving CDH1.
    Yamada M; Fukagawa T; Nakajima T; Asada K; Sekine S; Yamashita S; Okochi-Takada E; Taniguchi H; Kushima R; Oda I; Saito Y; Ushijima T; Katai H
    Gastric Cancer; 2014 Oct; 17(4):750-6. PubMed ID: 24037103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.